Market Cap 982,000.00
Revenue (ttm) 0.00
Net Income (ttm) -5.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 154,700
Avg Vol 3,998,536
Day's Range N/A - N/A
Shares Out 2.13M
Stochastic %K 16%
Beta 0.45
Analysts Strong Buy
Price Target $26.00

Company Profile

Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The...

Industry: Biotechnology
Sector: Healthcare
Phone: (713) 913-5608
Address:
2450 Holcombe Blvd., Suite X, Houston, United States
SKstocktwit24
SKstocktwit24 Aug. 18 at 9:49 PM
$SLRX I’m in let’s roll
0 · Reply
TwongStocks
TwongStocks Aug. 18 at 8:46 PM
Today's reverse split results. 2 of 3 closed green: $CHSN 1 for 80 Previous close $0.0394, $3.152 split-adjusted Today's close $3.28 🟢Up 4.06% $ENTO 1 for 3 Previous close $0.61, $1.83 split-adjusted Today's close $2.16 🟢Up 18.03% $SLRX 1 for 15 Previous close $0.4618, $6.927 split-adjusted Today's close $6.68 🔴Down 3.57%
1 · Reply
erb71
erb71 Aug. 18 at 3:09 PM
$SLRX Based on the reverse-split price adjustments, the targets of the bullish patterns, seen on the charts with various timeframes, have also accordingly changed. Some of the targets indicated by the double bottoms (DB) and falling wedges (FW) are as follows (not advice, just probabilities, realization of which are subject to patterns' validation, supporting factors such as progress in qualified financing and merger, market conditions, etc.): ~$10.60 (hourly chart FW's target) ~$35 (intermediate target of the 4-hour and daily regular hours (RH) DB) ~$55 (intermediate target of the 4-hour extended hours included (EH) chart DB) - corresponding to the highest price observed on July 29th. ~$63 (main target of the 4-hour and daily RH DB), ~14%+ above the July 29th highest. ~$104 (4-hour EH chart DB's main target) - a level close to the highest price on Jan 13. ~$126 (4-hour RH chart FW's target) ~$148 (4-hour EH chart FW's target) ~$198 (daily RH chart FW's target), ~83%+ above the Jan 13 highest
0 · Reply
Soupdog420
Soupdog420 Aug. 18 at 2:57 PM
$SLRX lol my avg price in one account 240 the other is 500 lplol pice of shit
0 · Reply
Finance2tymes
Finance2tymes Aug. 18 at 2:56 PM
$SLRX Am i the only one here !? 😂🤣
1 · Reply
impoorstonkssavemeplease
impoorstonkssavemeplease Aug. 18 at 1:48 PM
$SLRX i believe i just fucked up... stock price went up holdings went down... to 0. back to the poor house
0 · Reply
erb71
erb71 Aug. 18 at 1:13 PM
$SLRX A new 8-K has recently been filed regarding the new appointments (no outsiders or no departures). According to it, there has been a change in the CEO role, effective as of yesterday (the previous CEO continues to be a member of the Board), and the new CEO will also continue serving in his role as Executive Vice President and CFO of the company, which may underscore the company's focus on the ongoing merger process, given the filing also refers to the CEO’s previous roles in other companies that had gone through M&As. The following statement from the filing also seems to be substantial, as it directly refers to the finalization of the merger: "... support the Company as it works to finalize its previously announced merger transaction with Decoy Therapeutics Inc." https://investors.salariuspharma.com/node/12456/html
0 · Reply
Jwex2012
Jwex2012 Aug. 18 at 12:43 PM
$SLRX dropping in pre market when trading is stopped. Nice....
0 · Reply
TwongStocks
TwongStocks Aug. 18 at 12:04 PM
$CHSN $ENTO $SLRX All three with reverse splits this morning. Trading resumes at 9:00am ET. Reverse split details in the quoted post.
0 · Reply
Andresc1v
Andresc1v Aug. 18 at 9:40 AM
$SLRX vamos 🙂🙂😃
0 · Reply
Latest News on SLRX
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge

Jan 13, 2025, 2:12 PM EST - 7 months ago

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge


Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split

Oct 14, 2022, 8:43 AM EDT - 3 years ago

Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split


SKstocktwit24
SKstocktwit24 Aug. 18 at 9:49 PM
$SLRX I’m in let’s roll
0 · Reply
TwongStocks
TwongStocks Aug. 18 at 8:46 PM
Today's reverse split results. 2 of 3 closed green: $CHSN 1 for 80 Previous close $0.0394, $3.152 split-adjusted Today's close $3.28 🟢Up 4.06% $ENTO 1 for 3 Previous close $0.61, $1.83 split-adjusted Today's close $2.16 🟢Up 18.03% $SLRX 1 for 15 Previous close $0.4618, $6.927 split-adjusted Today's close $6.68 🔴Down 3.57%
1 · Reply
erb71
erb71 Aug. 18 at 3:09 PM
$SLRX Based on the reverse-split price adjustments, the targets of the bullish patterns, seen on the charts with various timeframes, have also accordingly changed. Some of the targets indicated by the double bottoms (DB) and falling wedges (FW) are as follows (not advice, just probabilities, realization of which are subject to patterns' validation, supporting factors such as progress in qualified financing and merger, market conditions, etc.): ~$10.60 (hourly chart FW's target) ~$35 (intermediate target of the 4-hour and daily regular hours (RH) DB) ~$55 (intermediate target of the 4-hour extended hours included (EH) chart DB) - corresponding to the highest price observed on July 29th. ~$63 (main target of the 4-hour and daily RH DB), ~14%+ above the July 29th highest. ~$104 (4-hour EH chart DB's main target) - a level close to the highest price on Jan 13. ~$126 (4-hour RH chart FW's target) ~$148 (4-hour EH chart FW's target) ~$198 (daily RH chart FW's target), ~83%+ above the Jan 13 highest
0 · Reply
Soupdog420
Soupdog420 Aug. 18 at 2:57 PM
$SLRX lol my avg price in one account 240 the other is 500 lplol pice of shit
0 · Reply
Finance2tymes
Finance2tymes Aug. 18 at 2:56 PM
$SLRX Am i the only one here !? 😂🤣
1 · Reply
impoorstonkssavemeplease
impoorstonkssavemeplease Aug. 18 at 1:48 PM
$SLRX i believe i just fucked up... stock price went up holdings went down... to 0. back to the poor house
0 · Reply
erb71
erb71 Aug. 18 at 1:13 PM
$SLRX A new 8-K has recently been filed regarding the new appointments (no outsiders or no departures). According to it, there has been a change in the CEO role, effective as of yesterday (the previous CEO continues to be a member of the Board), and the new CEO will also continue serving in his role as Executive Vice President and CFO of the company, which may underscore the company's focus on the ongoing merger process, given the filing also refers to the CEO’s previous roles in other companies that had gone through M&As. The following statement from the filing also seems to be substantial, as it directly refers to the finalization of the merger: "... support the Company as it works to finalize its previously announced merger transaction with Decoy Therapeutics Inc." https://investors.salariuspharma.com/node/12456/html
0 · Reply
Jwex2012
Jwex2012 Aug. 18 at 12:43 PM
$SLRX dropping in pre market when trading is stopped. Nice....
0 · Reply
TwongStocks
TwongStocks Aug. 18 at 12:04 PM
$CHSN $ENTO $SLRX All three with reverse splits this morning. Trading resumes at 9:00am ET. Reverse split details in the quoted post.
0 · Reply
Andresc1v
Andresc1v Aug. 18 at 9:40 AM
$SLRX vamos 🙂🙂😃
0 · Reply
Perpar
Perpar Aug. 18 at 8:20 AM
$SLRX 🔥🚀
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Aug. 16 at 10:36 AM
$SLRX SLRX- ​Based on the announcement from Salarius Pharmaceuticals, Inc. (SLRX), the reverse stock split of 1-for-15 will reduce the number of issued and outstanding shares from approximately 7.6 million to around 509,000.
0 · Reply
RainyDayFund
RainyDayFund Aug. 15 at 11:57 PM
$SLRX So sick of this trash. Money wasted. Management was never able to manage. Epic Fail.
0 · Reply
erb71
erb71 Aug. 15 at 11:11 PM
$SLRX Today's S-3 shelf registration gives the company flexibility to raise up to $50M through equity, debt, or warrants when market conditions allow. While it does not explicitly connect to the $6M “Qualified Financing” required for the Decoy merger, it provides the infrastructure to act quickly, and part of any raise could count toward that milestone. Together with the reverse split, likely Nasdaq Equity Standard compliance confirmation, and eventual Minimum Bid Price compliance, this filing strengthens the foundation for merger progress. Nothing is definite, but these steps set up a catalyst chain that could influence near-term price action.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 15 at 8:38 PM
$IDN $ATNI $SLRX $NMG $EJH Here are some mixed securities shelf filings from today: -- Intellicheck files $30M mixed securities shelf -- ATN International files $300M mixed securities shelf -- Salarius Pharmaceuticals files $50M mixed securities shelf -- Nouveau Monde files $350M mixed securities shelf16:22 NMG -- E-Home Household Service files $388.24M mixed securities shelf
1 · Reply
makedatbread88
makedatbread88 Aug. 15 at 8:25 PM
$SLRX Anyone know when the merger is supposed to close/what the "valuation" of the merger is supposed to be? Can't find anything Reverse split here on Monday with a super low float of only 509k... definitely one to watch this could be a big runner
1 · Reply
TwongStocks
TwongStocks Aug. 15 at 8:17 PM
Tracking three reverse splits on NASDAQ Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. $CHSN 1 for 80. Will reduce outstanding Class A shares from approx 85.91m to approx 1.07m and outstanding Class B shares from approx 5.67m to approx 70.9k. $ENTO 1 for 3. Will reduce outstanding shares from approx 4.77m to approx 1.59m. $SLRX 1 for 15. Will reduce outstanding shares from approx 7.6m to approx 509k.
0 · Reply
Perpar
Perpar Aug. 15 at 5:41 PM
$SLRX let's go 10% minimum today🔥🔥
0 · Reply
Perpar
Perpar Aug. 15 at 2:56 PM
$SLRX I think many will buy more today. We'll close green +15%, I estimate. Monday - Tuesday will fly. Everyone knows by now that a 500k float will explode.🚀
1 · Reply
erb71
erb71 Aug. 15 at 2:31 PM
0 · Reply
erb71
erb71 Aug. 15 at 12:33 PM
$SLRX @RichieGreen Regarding the information and predictions on the Equity Standard compliance progress, you can consider filings, news releases, announcements, and maybe summarizations on this thread as the attached one. On the Reverse Split and Minimum Bid Price compliance progress, similar resources may be taken into account.
0 · Reply
RichieGreen
RichieGreen Aug. 15 at 11:18 AM
$SLRX let me know something. If I am right or wrong. The RS don’t save them from compliance, because the capital should be more than 2,5M. Am I right?
0 · Reply